» Articles » PMID: 34039648

Radium-223-Induced Bystander Effects Cause DNA Damage and Apoptosis in Disseminated Tumor Cells in Bone Marrow

Overview
Journal Mol Cancer Res
Specialty Cell Biology
Date 2021 May 27
PMID 34039648
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Radiation-induced bystander effects have been implicated in contributing to the growth delay of disseminated tumor cells (DTC) caused by RaCl, an alpha particle-emitting radiopharmaceutical. To understand how RaCl affects the growth, we have quantified biological changes caused by direct effects of radiation and bystander effects caused by the emitted radiations on DTC and osteocytes. Characterizing these effects contribute to understanding the efficacy of alpha particle-emitting radiopharmaceuticals and guide expansion of their use clinically. MDA-MB-231 or MCF-7 human breast cancer cells were inoculated intratibially into nude mice that were previously injected intravenously with 50 or 600 kBq/kg RaCl. At 1-day and 3-days postinoculation, tibiae were harvested and examined for DNA damage (γ-H2AX foci) and apoptosis in osteocytes and cancer cells located within and beyond the range (70 μm) of alpha particles emitted from the bone surface. Irradiated and bystander MDA-MB-231 and MCF-7 cells harbored DNA damage. Bystander MDA-MB-231 cells expressed DNA damage at both treatment levels while bystander MCF-7 cells required the higher administered activity. Osteocytes also had DNA damage regardless of inoculated cancer cell line. The extent of DNA damage was quantified by increases in low (1-2 foci), medium (3-5 foci), and high (5+ foci) damage. MDA-MB-231 but not MCF-7 bystander cells showed increases in apoptosis in RaCl-treated animals, as did irradiated osteocytes. In summary, radiation-induced bystander effects contribute to DTC cytotoxicity caused by RaCl. IMPLICATIONS: This observation supports clinical investigation of the efficacy of RaCl to prevent breast cancer DTC from progressing to oligometastases.

Citing Articles

MIRD Pamphlet No. 31: MIRDcell V4-Artificial Intelligence Tools to Formulate Optimized Radiopharmaceutical Cocktails for Therapy.

Katugampola S, Wang J, Howell R J Nucl Med. 2024; 65(12):1965-1973.

PMID: 39448267 PMC: 11619582. DOI: 10.2967/jnumed.123.267238.


Immunological effects of radiopharmaceutical therapy.

Shea A, Idrissou M, Torres A, Chen T, Hernandez R, Morris Z Front Nucl Med. 2024; 4:1331364.

PMID: 39355211 PMC: 11440989. DOI: 10.3389/fnume.2024.1331364.


Precision Atomistic Structures of Actinium-/Radium-/Barium-Doped Lanthanide Nanoconstructs for Radiotherapeutic Applications.

Goswami M, Toro-Gonzalez M, Moon J, Davern S ACS Nano. 2024; 18(26):16577-16588.

PMID: 38885179 PMC: 11223473. DOI: 10.1021/acsnano.3c13213.


Development of Ac-doped biocompatible nanoparticles for targeted alpha therapy.

Toro-Gonzalez M, Akingbesote N, Bible A, Pal D, Sanders B, Ivanov A J Nanobiotechnology. 2024; 22(1):306.

PMID: 38825717 PMC: 11145892. DOI: 10.1186/s12951-024-02520-6.


Generalized methods for predicting biological response to mixed radiation types and calculating equieffective doses (EQDX).

Katugampola S, Hobbs R, Howell R Med Phys. 2023; 51(1):637-649.

PMID: 37558637 PMC: 11330299. DOI: 10.1002/mp.16650.


References
1.
Murphy J, Morton J . THE EFFECT OF ROENTGEN RAYS ON THE RATE OF GROWTH OF SPONTANEOUS TUMORS IN MICE. J Exp Med. 2009; 22(6):800-3. PMC: 2125377. DOI: 10.1084/jem.22.6.800. View

2.
Atkinson E, Delgado-Calle J . The Emerging Role of Osteocytes in Cancer in Bone. JBMR Plus. 2019; 3(3):e10186. PMC: 6419608. DOI: 10.1002/jbm4.10186. View

3.
Dallas S, Prideaux M, Bonewald L . The osteocyte: an endocrine cell ... and more. Endocr Rev. 2013; 34(5):658-90. PMC: 3785641. DOI: 10.1210/er.2012-1026. View

4.
Costes S, Chiolo I, Pluth J, Barcellos-Hoff M, Jakob B . Spatiotemporal characterization of ionizing radiation induced DNA damage foci and their relation to chromatin organization. Mutat Res. 2010; 704(1-3):78-87. PMC: 3951968. DOI: 10.1016/j.mrrev.2009.12.006. View

5.
Shiozawa Y . The Roles of Bone Marrow-Resident Cells as a Microenvironment for Bone Metastasis. Adv Exp Med Biol. 2020; 1226:57-72. DOI: 10.1007/978-3-030-36214-0_5. View